Shanghai Microport Ep Medtech Co., Ltd.

Stereotaxis' Magbot Magnetic Ablation Catheter Approved in China

5 months ago

• Stereotaxis received regulatory approval in China for its Magbot magnetic navigation ablation catheter, designed for minimally invasive cardiac procedures. • The approval follows recent clearance for Stereotaxis' Genesis robotic magnetic navigation system, expanding its footprint in the Chinese market. • Magbot, developed with MicroPort EP, integrates with robotic systems for precise navigation and real-time 3D cardiac modeling. • NMPA approved Magbot for treating drug-resistant persistent AFib, atrioventricular nodal reentrant tachycardia, and atrioventricular reentrant tachycardia.